Emerging biopharma companies face unique technology decisions as they prepare for launch. With growing expectations for AI-enabled decision-making, organizations must balance innovation with the realities of limited resources, regulatory complexity and evolving commercial needs.
In the inaugural episode of ZAIDYN Insights, host Kelly Hogan is joined by JR Raelin, Executive Director of Analytics and Insight at SynOx Therapeutics, and Krishna GS, Business Technology Solutions Manager at ZS, to discuss how emerging organizations can build a future-ready technology roadmap powered by connected data and agentic AI.
The conversation explores the importance of establishing strong data foundations before adopting AI, avoiding fragmented technology investments, and creating interoperable platforms that support commercial, medical and patient-focused teams. The guests also share practical guidance for implementation during the first 60–90 days, along with strategies for scaling technology as organizations grow.
Whether you're preparing for your first product launch or planning for long-term portfolio growth, this episode offers practical insights into building a technology ecosystem that transforms data into confident decisions.
Learn more about how ZAIDYN helps life sciences organizations connect data, decisions and execution: https://bit.ly/3RnYJGD
